COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment Article Swipe
The coronavirus disease 2019 (COVID-19) mortality rate in 55 African countries is almost 4.5 times lower than in the coronavirus disease 2019 (COVID-19) despite Africa having over 4.2 times more people. This mortality paradox is also evident when comparing Nigeria, a heavily populated, poorly vaccinated and weakly mandated country to Israel, a small, highly vaccinated and strictly mandated country. Nigeria has almost 4 times lower COVID mortality than Israel. In this Field of Vision perspective, I explain how this paradox has evolved drawing upon my academic, clinical and social experience. Since April 2020, I’ve developed and been using the Egyptian immune-modulatory Kelleni’s protocol to manage COVID-19 patients including pediatric, geriatric, pregnant, immune-compromised and other individuals suffering from multiple comorbidities. It’s unfortunate that severe acute respiratory syndrome coronavirus 2 is still evolving accompanied by more deaths. However in Africa, we’ve been able to live without anxiety or mandates throughout the pandemic because we trust science and adopted early treatment using safe, and effective repurposed drugs that have saved the majority of COVID-19 patients. This article represents an African and Egyptian tale of honor.
Related Topics
Concepts
Pandemic
Coronavirus disease 2019 (COVID-19)
Medicine
Mortality rate
Vaccination
Disease
Coronavirus
Demography
Infectious disease (medical specialty)
Immunology
Sociology
Internal medicine
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.5493/wjem.v14.i1.88674
- OA Status
- diamond
- Cited By
- 5
- References
- 38
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392959465
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392959465Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5493/wjem.v14.i1.88674Digital Object Identifier
- Title
-
COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatmentWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-03-19Full publication date if available
- Authors
-
Mina KelleniList of authors in order
- Landing page
-
https://doi.org/10.5493/wjem.v14.i1.88674Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.5493/wjem.v14.i1.88674Direct OA link when available
- Concepts
-
Pandemic, Coronavirus disease 2019 (COVID-19), Medicine, Mortality rate, Vaccination, Disease, Coronavirus, Demography, Infectious disease (medical specialty), Immunology, Sociology, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
5Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 2Per-year citation counts (last 5 years)
- References (count)
-
38Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392959465 |
|---|---|
| doi | https://doi.org/10.5493/wjem.v14.i1.88674 |
| ids.doi | https://doi.org/10.5493/wjem.v14.i1.88674 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38590304 |
| ids.openalex | https://openalex.org/W4392959465 |
| fwci | 5.19055999 |
| type | article |
| title | COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment |
| biblio.issue | 1 |
| biblio.volume | 14 |
| biblio.last_page | 88674 |
| biblio.first_page | 88674 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9965000152587891 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10833 |
| topics[1].field.id | https://openalex.org/fields/33 |
| topics[1].field.display_name | Social Sciences |
| topics[1].score | 0.9945999979972839 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3306 |
| topics[1].subfield.display_name | Health |
| topics[1].display_name | Vaccine Coverage and Hesitancy |
| topics[2].id | https://openalex.org/T10041 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9940000176429749 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | COVID-19 Clinical Research Studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C89623803 |
| concepts[0].level | 5 |
| concepts[0].score | 0.71647709608078 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q12184 |
| concepts[0].display_name | Pandemic |
| concepts[1].id | https://openalex.org/C3008058167 |
| concepts[1].level | 4 |
| concepts[1].score | 0.5517084002494812 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[1].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5269057154655457 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C179755657 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5262835621833801 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q58702 |
| concepts[3].display_name | Mortality rate |
| concepts[4].id | https://openalex.org/C22070199 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5182135701179504 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[4].display_name | Vaccination |
| concepts[5].id | https://openalex.org/C2779134260 |
| concepts[5].level | 2 |
| concepts[5].score | 0.47063159942626953 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[5].display_name | Disease |
| concepts[6].id | https://openalex.org/C2777648638 |
| concepts[6].level | 5 |
| concepts[6].score | 0.43168970942497253 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q57751738 |
| concepts[6].display_name | Coronavirus |
| concepts[7].id | https://openalex.org/C149923435 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4062405228614807 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q37732 |
| concepts[7].display_name | Demography |
| concepts[8].id | https://openalex.org/C524204448 |
| concepts[8].level | 3 |
| concepts[8].score | 0.2270708978176117 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[8].display_name | Infectious disease (medical specialty) |
| concepts[9].id | https://openalex.org/C203014093 |
| concepts[9].level | 1 |
| concepts[9].score | 0.2227131724357605 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[9].display_name | Immunology |
| concepts[10].id | https://openalex.org/C144024400 |
| concepts[10].level | 0 |
| concepts[10].score | 0.14222165942192078 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q21201 |
| concepts[10].display_name | Sociology |
| concepts[11].id | https://openalex.org/C126322002 |
| concepts[11].level | 1 |
| concepts[11].score | 0.1219232976436615 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[11].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/pandemic |
| keywords[0].score | 0.71647709608078 |
| keywords[0].display_name | Pandemic |
| keywords[1].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[1].score | 0.5517084002494812 |
| keywords[1].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.5269057154655457 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/mortality-rate |
| keywords[3].score | 0.5262835621833801 |
| keywords[3].display_name | Mortality rate |
| keywords[4].id | https://openalex.org/keywords/vaccination |
| keywords[4].score | 0.5182135701179504 |
| keywords[4].display_name | Vaccination |
| keywords[5].id | https://openalex.org/keywords/disease |
| keywords[5].score | 0.47063159942626953 |
| keywords[5].display_name | Disease |
| keywords[6].id | https://openalex.org/keywords/coronavirus |
| keywords[6].score | 0.43168970942497253 |
| keywords[6].display_name | Coronavirus |
| keywords[7].id | https://openalex.org/keywords/demography |
| keywords[7].score | 0.4062405228614807 |
| keywords[7].display_name | Demography |
| keywords[8].id | https://openalex.org/keywords/infectious-disease |
| keywords[8].score | 0.2270708978176117 |
| keywords[8].display_name | Infectious disease (medical specialty) |
| keywords[9].id | https://openalex.org/keywords/immunology |
| keywords[9].score | 0.2227131724357605 |
| keywords[9].display_name | Immunology |
| keywords[10].id | https://openalex.org/keywords/sociology |
| keywords[10].score | 0.14222165942192078 |
| keywords[10].display_name | Sociology |
| keywords[11].id | https://openalex.org/keywords/internal-medicine |
| keywords[11].score | 0.1219232976436615 |
| keywords[11].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.5493/wjem.v14.i1.88674 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210211663 |
| locations[0].source.issn | 2220-315X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2220-315X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | World Journal of Experimental Medicine |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | World Journal of Experimental Medicine |
| locations[0].landing_page_url | https://doi.org/10.5493/wjem.v14.i1.88674 |
| locations[1].id | pmid:38590304 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | World journal of experimental medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38590304 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10999069 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | acceptedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | True |
| locations[2].is_published | False |
| locations[2].raw_source_name | World J Exp Med |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10999069 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5009853287 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6290-6025 |
| authorships[0].author.display_name | Mina Kelleni |
| authorships[0].countries | EG |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I89466785 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacology, College of Medicine, Minia University, Minya 61111, Egypt. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I89466785 |
| authorships[0].institutions[0].ror | https://ror.org/02hcv4z63 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I89466785 |
| authorships[0].institutions[0].country_code | EG |
| authorships[0].institutions[0].display_name | Minia University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mina Thabet Kelleni |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Pharmacology, College of Medicine, Minia University, Minya 61111, Egypt. [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.5493/wjem.v14.i1.88674 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9965000152587891 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W4382894326, https://openalex.org/W3035105474, https://openalex.org/W4205698903, https://openalex.org/W4294968941, https://openalex.org/W4283819461, https://openalex.org/W3201614372, https://openalex.org/W3015753260, https://openalex.org/W3048636488, https://openalex.org/W3028088776, https://openalex.org/W3020901859 |
| cited_by_count | 5 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | doi:10.5493/wjem.v14.i1.88674 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210211663 |
| best_oa_location.source.issn | 2220-315X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2220-315X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | World Journal of Experimental Medicine |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | World Journal of Experimental Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.5493/wjem.v14.i1.88674 |
| primary_location.id | doi:10.5493/wjem.v14.i1.88674 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210211663 |
| primary_location.source.issn | 2220-315X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2220-315X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | World Journal of Experimental Medicine |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | World Journal of Experimental Medicine |
| primary_location.landing_page_url | https://doi.org/10.5493/wjem.v14.i1.88674 |
| publication_date | 2024-03-19 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4380869539, https://openalex.org/W3137872938, https://openalex.org/W4317802069, https://openalex.org/W4303699422, https://openalex.org/W4286255303, https://openalex.org/W4322631781, https://openalex.org/W4308043706, https://openalex.org/W4280543946, https://openalex.org/W3208673189, https://openalex.org/W3131626148, https://openalex.org/W3200352244, https://openalex.org/W4200473506, https://openalex.org/W4293740214, https://openalex.org/W4225607490, https://openalex.org/W4385948317, https://openalex.org/W3095100542, https://openalex.org/W3086091646, https://openalex.org/W3214865697, https://openalex.org/W3019420921, https://openalex.org/W4311904384, https://openalex.org/W3197384268, https://openalex.org/W3192353962, https://openalex.org/W4366590245, https://openalex.org/W4225775368, https://openalex.org/W4224528555, https://openalex.org/W3164232690, https://openalex.org/W4327681006, https://openalex.org/W4327733610, https://openalex.org/W4200294724, https://openalex.org/W3108504600, https://openalex.org/W4213337908, https://openalex.org/W3197361201, https://openalex.org/W3150728512, https://openalex.org/W4210840984, https://openalex.org/W3177233384, https://openalex.org/W4290999290, https://openalex.org/W3152652248, https://openalex.org/W4206717199 |
| referenced_works_count | 38 |
| abstract_inverted_index.2 | 127 |
| abstract_inverted_index.4 | 62 |
| abstract_inverted_index.I | 75 |
| abstract_inverted_index.a | 40, 51 |
| abstract_inverted_index.55 | 8 |
| abstract_inverted_index.In | 69 |
| abstract_inverted_index.an | 175 |
| abstract_inverted_index.by | 132 |
| abstract_inverted_index.in | 7, 17, 136 |
| abstract_inverted_index.is | 11, 34, 128 |
| abstract_inverted_index.my | 84 |
| abstract_inverted_index.of | 72, 169, 180 |
| abstract_inverted_index.or | 145 |
| abstract_inverted_index.to | 49, 103, 141 |
| abstract_inverted_index.we | 151 |
| abstract_inverted_index.4.2 | 27 |
| abstract_inverted_index.4.5 | 13 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.and | 45, 55, 87, 95, 112, 154, 160, 177 |
| abstract_inverted_index.has | 60, 80 |
| abstract_inverted_index.how | 77 |
| abstract_inverted_index.the | 18, 98, 148, 167 |
| abstract_inverted_index.2019 | 3, 21 |
| abstract_inverted_index.This | 31, 172 |
| abstract_inverted_index.able | 140 |
| abstract_inverted_index.also | 35 |
| abstract_inverted_index.been | 96, 139 |
| abstract_inverted_index.from | 116 |
| abstract_inverted_index.have | 165 |
| abstract_inverted_index.live | 142 |
| abstract_inverted_index.more | 29, 133 |
| abstract_inverted_index.over | 26 |
| abstract_inverted_index.rate | 6 |
| abstract_inverted_index.tale | 179 |
| abstract_inverted_index.than | 16, 67 |
| abstract_inverted_index.that | 121, 164 |
| abstract_inverted_index.this | 70, 78 |
| abstract_inverted_index.upon | 83 |
| abstract_inverted_index.when | 37 |
| abstract_inverted_index.2020, | 92 |
| abstract_inverted_index.April | 91 |
| abstract_inverted_index.COVID | 65 |
| abstract_inverted_index.Field | 71 |
| abstract_inverted_index.Since | 90 |
| abstract_inverted_index.acute | 123 |
| abstract_inverted_index.drugs | 163 |
| abstract_inverted_index.early | 156 |
| abstract_inverted_index.lower | 15, 64 |
| abstract_inverted_index.other | 113 |
| abstract_inverted_index.safe, | 159 |
| abstract_inverted_index.saved | 166 |
| abstract_inverted_index.still | 129 |
| abstract_inverted_index.times | 14, 28, 63 |
| abstract_inverted_index.trust | 152 |
| abstract_inverted_index.using | 97, 158 |
| abstract_inverted_index.Africa | 24 |
| abstract_inverted_index.It’s | 119 |
| abstract_inverted_index.I’ve | 93 |
| abstract_inverted_index.Vision | 73 |
| abstract_inverted_index.almost | 12, 61 |
| abstract_inverted_index.having | 25 |
| abstract_inverted_index.highly | 53 |
| abstract_inverted_index.honor. | 181 |
| abstract_inverted_index.manage | 104 |
| abstract_inverted_index.poorly | 43 |
| abstract_inverted_index.severe | 122 |
| abstract_inverted_index.small, | 52 |
| abstract_inverted_index.social | 88 |
| abstract_inverted_index.weakly | 46 |
| abstract_inverted_index.Africa, | 137 |
| abstract_inverted_index.African | 9, 176 |
| abstract_inverted_index.However | 135 |
| abstract_inverted_index.Israel, | 50 |
| abstract_inverted_index.Israel. | 68 |
| abstract_inverted_index.Nigeria | 59 |
| abstract_inverted_index.adopted | 155 |
| abstract_inverted_index.anxiety | 144 |
| abstract_inverted_index.article | 173 |
| abstract_inverted_index.because | 150 |
| abstract_inverted_index.country | 48 |
| abstract_inverted_index.deaths. | 134 |
| abstract_inverted_index.despite | 23 |
| abstract_inverted_index.disease | 2, 20 |
| abstract_inverted_index.drawing | 82 |
| abstract_inverted_index.evident | 36 |
| abstract_inverted_index.evolved | 81 |
| abstract_inverted_index.explain | 76 |
| abstract_inverted_index.heavily | 41 |
| abstract_inverted_index.paradox | 33, 79 |
| abstract_inverted_index.people. | 30 |
| abstract_inverted_index.science | 153 |
| abstract_inverted_index.we’ve | 138 |
| abstract_inverted_index.without | 143 |
| abstract_inverted_index.COVID-19 | 105, 170 |
| abstract_inverted_index.Egyptian | 99, 178 |
| abstract_inverted_index.Nigeria, | 39 |
| abstract_inverted_index.clinical | 86 |
| abstract_inverted_index.country. | 58 |
| abstract_inverted_index.evolving | 130 |
| abstract_inverted_index.majority | 168 |
| abstract_inverted_index.mandated | 47, 57 |
| abstract_inverted_index.mandates | 146 |
| abstract_inverted_index.multiple | 117 |
| abstract_inverted_index.pandemic | 149 |
| abstract_inverted_index.patients | 106 |
| abstract_inverted_index.protocol | 102 |
| abstract_inverted_index.strictly | 56 |
| abstract_inverted_index.syndrome | 125 |
| abstract_inverted_index.academic, | 85 |
| abstract_inverted_index.comparing | 38 |
| abstract_inverted_index.countries | 10 |
| abstract_inverted_index.developed | 94 |
| abstract_inverted_index.effective | 161 |
| abstract_inverted_index.including | 107 |
| abstract_inverted_index.mortality | 5, 32, 66 |
| abstract_inverted_index.patients. | 171 |
| abstract_inverted_index.pregnant, | 110 |
| abstract_inverted_index.suffering | 115 |
| abstract_inverted_index.treatment | 157 |
| abstract_inverted_index.(COVID-19) | 4, 22 |
| abstract_inverted_index.geriatric, | 109 |
| abstract_inverted_index.pediatric, | 108 |
| abstract_inverted_index.populated, | 42 |
| abstract_inverted_index.represents | 174 |
| abstract_inverted_index.repurposed | 162 |
| abstract_inverted_index.throughout | 147 |
| abstract_inverted_index.vaccinated | 44, 54 |
| abstract_inverted_index.Kelleni’s | 101 |
| abstract_inverted_index.accompanied | 131 |
| abstract_inverted_index.coronavirus | 1, 19, 126 |
| abstract_inverted_index.experience. | 89 |
| abstract_inverted_index.individuals | 114 |
| abstract_inverted_index.respiratory | 124 |
| abstract_inverted_index.unfortunate | 120 |
| abstract_inverted_index.perspective, | 74 |
| abstract_inverted_index.comorbidities. | 118 |
| abstract_inverted_index.immune-modulatory | 100 |
| abstract_inverted_index.immune-compromised | 111 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5009853287 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 1 |
| corresponding_institution_ids | https://openalex.org/I89466785 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8899999856948853 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.88619902 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |